Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment

Abstract Liver fibrosis is a danger signal indicating a huge risk of liver cancer occurrence, but there is still no effective clinical means to regulate the progress of liver fibrosis. Although a variety of drugs targeting SYK have been developed for tumors and autoimmune diseases, the mechanism and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xuejiao Chen, Ziyi Wang, Sheng Han, Zeng Wang, Yu Zhang, Xiangdong Li, Nan Xia, Wenjie Yu, Chenyang Jia, Yong Ni, Liyong Pu
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/abe1951af52e48a485781d8fef506221
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:abe1951af52e48a485781d8fef506221
record_format dspace
spelling oai:doaj.org-article:abe1951af52e48a485781d8fef5062212021-12-05T12:04:26ZTargeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment10.1038/s41419-021-04403-22041-4889https://doaj.org/article/abe1951af52e48a485781d8fef5062212021-12-01T00:00:00Zhttps://doi.org/10.1038/s41419-021-04403-2https://doaj.org/toc/2041-4889Abstract Liver fibrosis is a danger signal indicating a huge risk of liver cancer occurrence, but there is still no effective clinical means to regulate the progress of liver fibrosis. Although a variety of drugs targeting SYK have been developed for tumors and autoimmune diseases, the mechanism and specific efficacy of SYK’s role in liver fibrosis are not yet clear. Our studies based on chronic CCL4, bile duct ligation, and subacute TAA mouse models show that SYK in monocyte-derived macrophages (MoMFs) is fully dependent on phosphorylation of Erk to up-regulate the expression of Hif1α, thereby forming the crosstalk with SYK to drive liver fibrosis progress. We have evaluated the ability of the small molecule SYK inhibitor GS9973 in a variety of models. Contrary to previous impressions, high-frequency administration of GS9973 will aggravate CCL4-induced liver fibrosis, which is especially unsuitable for patients with cholestasis whose clinical features are bile duct obstruction. In addition, we found that inhibition of MoMFs SYK impairs the expression of CXCL1, on one hand, it reduces the recruitment of CD11bhiLy6Chi inflammatory cells, and on the other hand, it promotes the phenotype cross-dress process of pro-resolution MoMFs, thereby remodeling the chronic inflammatory environment of the fibrotic liver. Our further findings indicate that on the basis of the administration of CCR2/CCR5 dual inhibitor Cenicriviroc, further inhibiting MoMFs SYK may give patients with fibrosis additional benefits.Xuejiao ChenZiyi WangSheng HanZeng WangYu ZhangXiangdong LiNan XiaWenjie YuChenyang JiaYong NiLiyong PuNature Publishing GrouparticleCytologyQH573-671ENCell Death and Disease, Vol 12, Iss 12, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Cytology
QH573-671
spellingShingle Cytology
QH573-671
Xuejiao Chen
Ziyi Wang
Sheng Han
Zeng Wang
Yu Zhang
Xiangdong Li
Nan Xia
Wenjie Yu
Chenyang Jia
Yong Ni
Liyong Pu
Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment
description Abstract Liver fibrosis is a danger signal indicating a huge risk of liver cancer occurrence, but there is still no effective clinical means to regulate the progress of liver fibrosis. Although a variety of drugs targeting SYK have been developed for tumors and autoimmune diseases, the mechanism and specific efficacy of SYK’s role in liver fibrosis are not yet clear. Our studies based on chronic CCL4, bile duct ligation, and subacute TAA mouse models show that SYK in monocyte-derived macrophages (MoMFs) is fully dependent on phosphorylation of Erk to up-regulate the expression of Hif1α, thereby forming the crosstalk with SYK to drive liver fibrosis progress. We have evaluated the ability of the small molecule SYK inhibitor GS9973 in a variety of models. Contrary to previous impressions, high-frequency administration of GS9973 will aggravate CCL4-induced liver fibrosis, which is especially unsuitable for patients with cholestasis whose clinical features are bile duct obstruction. In addition, we found that inhibition of MoMFs SYK impairs the expression of CXCL1, on one hand, it reduces the recruitment of CD11bhiLy6Chi inflammatory cells, and on the other hand, it promotes the phenotype cross-dress process of pro-resolution MoMFs, thereby remodeling the chronic inflammatory environment of the fibrotic liver. Our further findings indicate that on the basis of the administration of CCR2/CCR5 dual inhibitor Cenicriviroc, further inhibiting MoMFs SYK may give patients with fibrosis additional benefits.
format article
author Xuejiao Chen
Ziyi Wang
Sheng Han
Zeng Wang
Yu Zhang
Xiangdong Li
Nan Xia
Wenjie Yu
Chenyang Jia
Yong Ni
Liyong Pu
author_facet Xuejiao Chen
Ziyi Wang
Sheng Han
Zeng Wang
Yu Zhang
Xiangdong Li
Nan Xia
Wenjie Yu
Chenyang Jia
Yong Ni
Liyong Pu
author_sort Xuejiao Chen
title Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment
title_short Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment
title_full Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment
title_fullStr Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment
title_full_unstemmed Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment
title_sort targeting syk of monocyte-derived macrophages regulates liver fibrosis via crosstalking with erk/hif1α and remodeling liver inflammatory environment
publisher Nature Publishing Group
publishDate 2021
url https://doaj.org/article/abe1951af52e48a485781d8fef506221
work_keys_str_mv AT xuejiaochen targetingsykofmonocytederivedmacrophagesregulatesliverfibrosisviacrosstalkingwitherkhif1aandremodelingliverinflammatoryenvironment
AT ziyiwang targetingsykofmonocytederivedmacrophagesregulatesliverfibrosisviacrosstalkingwitherkhif1aandremodelingliverinflammatoryenvironment
AT shenghan targetingsykofmonocytederivedmacrophagesregulatesliverfibrosisviacrosstalkingwitherkhif1aandremodelingliverinflammatoryenvironment
AT zengwang targetingsykofmonocytederivedmacrophagesregulatesliverfibrosisviacrosstalkingwitherkhif1aandremodelingliverinflammatoryenvironment
AT yuzhang targetingsykofmonocytederivedmacrophagesregulatesliverfibrosisviacrosstalkingwitherkhif1aandremodelingliverinflammatoryenvironment
AT xiangdongli targetingsykofmonocytederivedmacrophagesregulatesliverfibrosisviacrosstalkingwitherkhif1aandremodelingliverinflammatoryenvironment
AT nanxia targetingsykofmonocytederivedmacrophagesregulatesliverfibrosisviacrosstalkingwitherkhif1aandremodelingliverinflammatoryenvironment
AT wenjieyu targetingsykofmonocytederivedmacrophagesregulatesliverfibrosisviacrosstalkingwitherkhif1aandremodelingliverinflammatoryenvironment
AT chenyangjia targetingsykofmonocytederivedmacrophagesregulatesliverfibrosisviacrosstalkingwitherkhif1aandremodelingliverinflammatoryenvironment
AT yongni targetingsykofmonocytederivedmacrophagesregulatesliverfibrosisviacrosstalkingwitherkhif1aandremodelingliverinflammatoryenvironment
AT liyongpu targetingsykofmonocytederivedmacrophagesregulatesliverfibrosisviacrosstalkingwitherkhif1aandremodelingliverinflammatoryenvironment
_version_ 1718372276891549696